首页> 美国卫生研究院文献>ISRN Obstetrics and Gynecology >Predictive and Prognostic Factors in Definition of Risk Groups in Endometrial Carcinoma
【2h】

Predictive and Prognostic Factors in Definition of Risk Groups in Endometrial Carcinoma

机译:子宫内膜癌危险人群定义中的预测和预后因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background. The aim was to evaluate predictive and prognostic factors in a large consecutive series of endometrial carcinomas and to discuss pre- and postoperative risk groups based on these factors. Material and Methods. In a consecutive series of 4,543 endometrial carcinomas predictive and prognostic factors were analyzed with regard to recurrence rate and survival. The patients were treated with primary surgery and adjuvant radiotherapy. Two preoperative and three postoperative risk groups were defined. DNA ploidy was included in the definitions. Eight predictive or prognostic factors were used in multivariate analyses. Results. The overall recurrence rate of the complete series was 11.4%. Median time to relapse was 19.7 months. In a multivariate logistic regression analysis, FIGO grade, myometrial infiltration, and DNA ploidy were independent and statistically predictive factors with regard to recurrence rate. The 5-year overall survival rate was 73%. Tumor stage was the single most important factor with FIGO grade on the second place. DNA ploidy was also a significant prognostic factor. In the preoperative risk group definitions three factors were used: histology, FIGO grade, and DNA ploidy. Conclusions. DNA ploidy was an important and significant predictive and prognostic factor and should be used both in preoperative and postoperative risk group definitions.
机译:背景。目的是评估一系列大系列子宫内膜癌的预测和预后因素,并基于这些因素讨论术前和术后风险组。材料与方法。在连续的4,543例子宫内膜癌系列中,就复发率和生存率分析了预测和预后因素。患者接受了一次外科手术和辅助放疗。定义了两个术前和三个术后风险组。 DNA倍性被包括在定义中。八项预测或预后因素用于多元分析。结果。完整系列的总复发率为11.4%。复发的中位时间为19.7个月。在多因素logistic回归分析中,FIGO分级,肌层浸润和DNA倍性在复发率方面是独立的且具有统计意义的预测因素。 5年总生存率为73%。肿瘤分期是FIGO等级第二的最重要因素。 DNA倍性也是重要的预后因素。在术前风险组定义中,使用了三个因素:组织学,FIGO分级和DNA倍性。结论。 DNA倍性是重要且重要的预测和预后因素,应在术前和术后风险组定义中使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号